the pharmacokinetics of pirtobrutinib
Published 3 years ago • 824 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
1:35
pirtobrutinib in r/r fl: results from the bruin study
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
1:41
developing novel gene therapy approaches for hemoglobinopathies
-
8:34
hct in mds: cell source and conditioning type
-
1:03:42
october 4, 2024 vmr with reza & rabih - fever & pancytopenia
-
1:28:58
frcpath part 1 exam huddle recording
-
6:05
updates in pv treatment: the efficacy of ropeginterferon alfa-2b
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:01
pirtobrutinib, venetoclax, and rituximab in the treatment of r/r cll: insights from the bruin trial
-
1:47
shared treatment decision-making
-
1:17
keynote-667: pembrolizumab plus copdac-28 for high-risk chl with slow early response to oepa
-
1:45
a phase ii study of elritercept for lower-risk mds
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
0:59
the safety and efficacy of etavopivat in scd
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
5:07
daratumumab in the management of al amyloidosis
-
1:02
maintenance therapy following treatment for amyloidosis